Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
Journal of Psychiatric Practice · 2006-03-01 · Randomised trial
Abstract
OBJECTIVE: To compare oral risperidone and intramuscular (IM) haloperidol, both in combination with IM lorazepam, in the management of acute agitation and psychosis in the medical emergency department. METHODS: In this prospective, randomized, placebo-controlled, double-blind study of 30 patients presenting to the emergency department with acute agitation and/or psychosis, three groups of 10 patients received oral and IM medications: 1) 2 mg oral risperidone and 2 mg IM lorazepam; 2) 5 mg oral haloperidol and 2 mg IM lorazepam; 3) oral placebo and 2 mg IM lorazepam. Each treatment group received both an injection and a tablet to reduce treatment group variability. Patients were evaluated using the Brief Psychiatric Rating Scale (BPRS) and the Positive and Negative Syndrome Scale (PANSS) before receiving medication and at 30 and 90 minutes after medication was administered. The intergroup mean percent reductions in rating scale scores were compared using ANOVA, chi-square, and Kruskal-Wallis tests. RESULTS: There were no statistically significant differences among the groups at any point. The two groups receiving an antipsychotic plus lorazepam showed a trend towards increased symptom reduction compared with the group receiving lorazepam alone, although this trend was not statistically significant. CONCLUSIONS: Lorazepam alone was as effective as lorazepam plus haloperidol or lorazepam plus risperidone in this small trial. While not statistically significant, a trend toward better outcomes with combined treatment warrants further study.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Sedatives & anxiolytics · Other benzodiazepines & Z-drugs · Antipsychotics
Related articles
- Treatment of Agitation With Lorazepam in Clinical Practice: A Systematic Review. (Front Psychiatry, 2021)
- Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis. (Hum Psychopharmacol, 2016)
- Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department. (Acad Emerg Med, 2021)
- Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study. (Am J Emerg Med, 2021)
- Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial. (J Formos Med Assoc, 2015)
- Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. (J Clin Psychopharmacol, 2007)